Skip to content

Clinical trials

Completed Papillomavirus Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Status: Completed Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20111
20141
20162
20194
20205
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Beijing Health Guard Biotechnology, Inc2
National Vaccine and Serum Institute, China2
Shanghai Bovax Biotechnology Co., Ltd.2
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.2
Shanghai Zerun Biotechnology Co.,Ltd2
Jun Zhang1
Merck Sharp & Dohme LLC1
Xiamen Innovax Biotech Co., Ltd1
Zhujiang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections18
Uterine Cervical Neoplasms8
Condylomata Acuminata5
Vulvar Neoplasms3
Anus Neoplasms2
Uterine Cervical Dysplasia2
Vaginal Neoplasms2
Persistent Infection1
Sexually Transmitted Diseases1
Squamous Intraepithelial Lesions1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.